Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Rat (Rattus) SEMA4D Antikörper:
anti-Human SEMA4D Antikörper:
anti-Mouse (Murine) SEMA4D Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal SEMA4D Primary Antibody für FACS - ABIN610341
Drivas, Shih, Coutavas, Rush, DEustachio: Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line. in Molecular and cellular biology 1990
Show all 2 Pubmed References
Human Monoclonal SEMA4D Primary Antibody für FACS - ABIN4896537
Li, He, Zhang, Guo, Zhou, Zhang, Wang, Zhao, Li, Zuo, Fan, Jia: Interferon-α-induced CD100 on naïve CD8+ T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction. in The Journal of international medical research 2017
Cynomolgus Monoclonal SEMA4D Primary Antibody für FACS - ABIN2477982
Senn, Jungi: Neutrophil migration in health and disease. in Seminars in hematology 1975
Show all 2 Pubmed References
Cynomolgus Monoclonal SEMA4D Primary Antibody für FACS, IP - ABIN2477980
Mizrahi, Markel, Porgador, Bushkin, Mandelboim: CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72. in PLoS ONE 2007
Show all 2 Pubmed References
Human Monoclonal SEMA4D Primary Antibody für ELISA, WB - ABIN564579
Luque, Gutierrez, Debbas, Martins, Puech-Leao, Porto, Coelho, Boumsell, Kalil, Stolf: Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells. in PLoS ONE 2013
Rat (Rattus) Polyclonal SEMA4D Primary Antibody für IF/ICC, IHC - ABIN2910752
Zhou, Li, Jin, Wu, He, Wang, Lei, Hu: Sema4D/PlexinB1 inhibition ameliorates blood-brain barrier damage and improves outcome after stroke in rats. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2018
Combined detection of tumor-associated macrophages markers, CD68 and Sema4D, in gastric carcinoma tissue shows potential to predict the trend of gastric carcinoma progression.
SEMA4D coordinates with VEGF during angiogenesis via plexin-B1 in epithelial ovarian cancer.
Advanced peri-implantitis lesions showed higher levels of gene expression for Sem3A and Sem4D and lower levels of Sem4A in comparison to tissues obtained from a healthy dental implant.
knockdown of Sema4D in Head and neck squamous cell carcinomas (HNSCCs)cells inhibited tumor growth and decreased the number of osteoclasts in a mouse xenograft model. Taken together, IGF-I-driven production of Sema4D in HNSCCs promotes osteoclastogenesis and bone invasion.
The results obtained make significant adjustments in understanding of Seam4D effects in lymphoid cells.
describe the transfection, purification, and visualization of Fc-tagged SEMA4D (semaphorin 4D) recombinant protein
describe the application of in vitro migration and tubulogenesis assays and the directed in vivo angiogenesis assay (DIVAA) in the measurement of the angiogenic potential of cell-derived and soluble SEMA4D
The positive expression of both Sema4D and PlexinB1 was found to be an independent risk factor for a worse survival in colorectal cancer.
Serum levels of soluble SEMA4D were elevated in patients with ANCA-associated vasculitis. Cell-surface expression of SEMA4D was downregulated, a consequence of proteolytic cleavage of membrane SEMA4D. Soluble SEMA4D exerted pro-inflammatory effects on endothelial cells. Membranous SEMA4D on neutrophils bound to plexin B2 on endothelial cells, and this interaction decreased NET formation.
We identified a novel genome-wide significant African-specific locus for BMI (SEMA4D, rs80068415). A novel variant in SEMA4D was significantly associated with body mass index. Carriers of the C allele were 4.6 BMI units heavier than carriers of the T allele.
A critical pathogenic engagement of Semaphorin 4D produced by gamma delta T cells in the development of medication-related osteonecrosis of the jaw
Our results identified FGL2, GAL, SEMA4D, SEMA7A, and IDO1 as new candidate genes that could be involved in MSCs-mediated immunomodulation. FGL2, GAL, SEMA4D, SEMA7A, and IDO1 genes appeared to be differentially transcribed in the different MSC populations. Moreover, these genes were not similarly modulated following MSCs-exposure to inflammatory signals
Interferon-alpha-induced CD100 expression on naive CD8(+) T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction.
In this review, we summarized the current findings on neuroimmune Sema4A and Sema4D molecules in chronic inflammation underlying many diseases and discussed their positive or negative impacts on the implicated molecular and cellular processes
we have identified a novel reverse signaling pathway acting through Tiam1 and Rac that promotes aggressive behavior in OSCC expressing S4D and PB1.
sema 4D was the direct target of miR-214 and was negatively regulated by miR-214 in ovarian cancer cells
Tax and semaphorin 4D released from lymphocytes infected with human lymphotropic virus type 1 and inhibit neurite growth in a neuron cell line.
This assay specifically and reproducibly measured cSEMA4D saturation and expression levels. Evaluation of the SEMA4D-specific PD markers were critical in determining the clinical saturation threshold of cSEMA4D by VX15/2503
Serum sSema4D levels are increased in patients with atrial fibrillation and are independently associated with atrial remodeling
Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer.
Cell surface receptor for PLXN1B and PLXNB2 that plays an important role in cell-cell signaling. Promotes reorganization of the actin cytoskeleton and plays a role in axonal growth cone guidance in the developing central nervous system. Regulates dendrite and axon branching and morphogenesis. Promotes the migration of cerebellar granule cells and of endothelial cells. Plays a role in the immune system\; induces B-cells to aggregate and improves their viability (in vitro). Promotes signaling via SRC and PTK2B/PYK2, which then mediates activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Interaction with PLXNB1 mediates activation of RHOA (By similarity).
, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4D
, M-sema G
, sema J
, semaphorin H
, semaphorin-C-like 2
, semaphorin 4D